Iaculor Injection Overview

  • Founded
  • 2006
  • Status
  • Private
  • Latest Deal Type
  • 2ndary - Private

Iaculor Injection General Information


Developer of medical devices designed to offer delivery of vaccines in either liquid or powder form. The company's devices are precise, effective, safe, low-cost and simple to use, enabling healthcare providers to get needle-free medical devices for drug delivery and improve the lives of the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Medical Supplies
Primary Office
  • 3201 Jean-Migneault Street
  • Fleurimont
  • Sherbrooke, Quebec J1H 5H3
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Iaculor Injection Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Mar-2021 Completed Startup
1. Seed Round 28-Jun-2006 Completed Startup
To view Iaculor Injection’s complete valuation and funding history, request access »

Iaculor Injection Executive Team (2)

Name Title Board Seat Contact Info
Jean Gosselin Co-Founder, Chief Executive Officer & President
Martin Brouillette Co-Founder
To view Iaculor Injection’s complete executive team members history, request access »